NPI: 1679525919 · CLEVELAND, OH 44195 · General Acute Care Hospital · NPI assigned 05/16/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 05/16/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,362,709 | $57.44M |
| 2019 | 1,578,774 | $64.02M |
| 2020 | 1,268,654 | $62.81M |
| 2021 | 1,755,736 | $86.60M |
| 2022 | 2,042,399 | $99.87M |
| 2023 | 4,407,896 | $278.95M |
| 2024 | 3,600,099 | $213.85M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,534,307 | 2,108,085 | $269.98M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 518,214 | 448,053 | $45.28M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 582,362 | 517,566 | $37.38M |
| J2350 | Injection, ocrelizumab, 1 mg | 1,801 | 1,329 | $34.27M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 619,198 | 575,826 | $21.59M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 806,649 | 738,040 | $20.33M |
| J9271 | Injection, pembrolizumab, 1 mg | 1,649 | 1,042 | $14.56M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 238,829 | 206,898 | $14.56M |
| 96361 | Intravenous infusion, hydration; each additional hour | 30,936 | 22,003 | $11.30M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 13,547 | 10,607 | $10.12M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 101,964 | 50,594 | $8.69M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 75,564 | 63,480 | $7.85M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 90,120 | 60,276 | $6.98M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 79,897 | 56,615 | $6.68M |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 63,706 | 40,654 | $6.33M |
| 81513 | 40,466 | 33,807 | $6.31M | |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,363 | 1,093 | $5.87M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 28,386 | 16,823 | $5.52M |
| 96127 | 57,871 | 47,968 | $5.47M | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 14,524 | 10,579 | $5.20M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 146,885 | 133,210 | $5.00M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 34,206 | 29,446 | $4.74M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 34,289 | 27,316 | $4.50M |
| 87631 | 21,694 | 18,213 | $4.46M | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 9,136 | 6,875 | $4.24M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 86,131 | 43,501 | $4.13M |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 2,702 | 1,941 | $4.06M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 15,733 | 13,589 | $3.93M |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 834 | 477 | $3.91M |
| 80053 | Comprehensive metabolic panel | 302,267 | 240,129 | $3.75M |
| 70450 | Computed tomography, head or brain; without contrast material | 44,727 | 39,618 | $3.66M |
| 20610 | 31,755 | 20,161 | $3.59M | |
| 99233 | Prolong inpt eval add15 m | 133,359 | 51,536 | $3.59M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 32,194 | 27,714 | $3.52M |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 643 | 497 | $3.31M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 5,385 | 4,133 | $3.22M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 34,846 | 26,968 | $3.20M |
| 77386 | 6,598 | 701 | $2.88M | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 24,773 | 18,259 | $2.87M |
| 76819 | Fetal biophysical profile; without non-stress testing | 36,854 | 18,722 | $2.84M |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 10,144 | 5,353 | $2.82M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 22,305 | 13,083 | $2.77M |
| 99232 | Subsequent hospital care, per day, moderate complexity | 149,057 | 64,347 | $2.69M |
| 99215 | Prolong outpt/office vis | 52,079 | 48,369 | $2.65M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 21,361 | 17,617 | $2.63M |
| 95720 | 23,210 | 10,073 | $2.62M | |
| 76801 | 24,615 | 15,822 | $2.61M | |
| 95811 | 5,776 | 4,322 | $2.55M | |
| 96415 | 7,238 | 4,662 | $2.50M | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 454,006 | 389,398 | $2.44M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 55,327 | 49,278 | $2.44M |
| J9299 | Injection, nivolumab, 1 mg | 649 | 281 | $2.40M |
| J0178 | Injection, aflibercept, 1 mg | 2,260 | 1,860 | $2.36M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 15,369 | 14,114 | $2.35M |
| 67028 | Intravitreal injection of a pharmacologic agent | 20,315 | 13,750 | $2.34M |
| 64615 | 11,417 | 8,200 | $2.29M | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 16,393 | 12,750 | $2.27M |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 20,246 | 18,526 | $2.22M |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 21,444 | 13,366 | $2.15M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 15,824 | 13,548 | $2.12M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 18,593 | 14,719 | $2.11M |
| 95715 | 2,363 | 814 | $2.09M | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 2,920 | 2,217 | $2.03M |
| 59025 | Fetal non-stress test | 12,802 | 7,815 | $1.90M |
| G0378 | Hospital observation service, per hour | 18,720 | 8,446 | $1.80M |
| 95951 | 16,273 | 6,443 | $1.78M | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 3,344 | 2,057 | $1.75M |
| 95806 | 4,308 | 3,724 | $1.74M | |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,731 | 744 | $1.74M |
| 90677 | 16,875 | 14,699 | $1.73M | |
| 95886 | 8,577 | 6,322 | $1.73M | |
| J2323 | Injection, natalizumab, 1 mg | 464 | 379 | $1.72M |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 1,616 | 1,357 | $1.68M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1,112 | 920 | $1.68M |
| 92134 | 63,789 | 41,786 | $1.64M | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 982 | 767 | $1.63M |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 10,816 | 7,564 | $1.54M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 52,563 | 50,363 | $1.54M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 6,789 | 5,246 | $1.53M |
| 71046 | Radiologic examination, chest; 2 views | 135,940 | 123,840 | $1.45M |
| 96161 | 9,331 | 8,081 | $1.44M | |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | 295 | 248 | $1.43M |
| 76830 | Ultrasound, transvaginal | 29,480 | 21,599 | $1.36M |
| 52000 | 1,996 | 1,758 | $1.35M | |
| 11102 | 3,523 | 2,853 | $1.34M | |
| 96160 | 7,800 | 6,029 | $1.31M | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 1,711 | 1,400 | $1.30M |
| 95813 | 1,962 | 1,581 | $1.29M | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 23,737 | 20,538 | $1.28M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 7,056 | 6,090 | $1.27M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 996 | 809 | $1.25M |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 8,873 | 6,867 | $1.22M |
| 90791 | Psychiatric diagnostic evaluation | 8,616 | 6,909 | $1.21M |
| 36415 | Collection of venous blood by venipuncture | 581,641 | 449,299 | $1.20M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 289,296 | 227,384 | $1.18M |
| 76813 | 16,978 | 10,815 | $1.14M | |
| 90834 | Psychotherapy, 45 minutes with patient | 16,316 | 9,649 | $1.12M |
| 84443 | Thyroid stimulating hormone (TSH) | 95,475 | 82,485 | $1.12M |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 503 | 412 | $1.12M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 145,673 | 127,689 | $1.11M |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 20,903 | 12,222 | $1.06M |
| 11104 | 2,169 | 1,769 | $1.05M | |
| 19318 | 198 | 142 | $1.03M | |
| 71045 | Radiologic examination, chest; single view | 209,119 | 142,025 | $1.03M |
| 43235 | 2,439 | 1,985 | $1.03M | |
| 94060 | 19,649 | 15,442 | $1.03M | |
| 95782 | 1,666 | 1,274 | $1.01M | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 16,244 | 10,617 | $1.01M |
| J0490 | Injection, belimumab, 10 mg | 627 | 279 | $1.01M |
| 49083 | 4,673 | 2,083 | $1000K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 920 | 773 | $988K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 4,426 | 3,844 | $986K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7,756 | 6,649 | $984K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 61,301 | 53,271 | $957K |
| 80061 | Lipid panel | 95,290 | 83,668 | $955K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 19,854 | 18,900 | $948K |
| 31231 | 7,918 | 5,694 | $946K | |
| 93325 | 28,217 | 22,083 | $940K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 38,335 | 35,302 | $937K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1,394 | 1,078 | $931K |
| 97153 | Adaptive behavior treatment by protocol, administered by technician, each 15 minutes | 6,369 | 758 | $924K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 2,054 | 1,755 | $924K |
| J2357 | Injection, omalizumab, 5 mg | 1,100 | 499 | $922K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 23,442 | 20,859 | $905K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 83,229 | 71,698 | $903K |
| 92551 | 14,442 | 12,854 | $857K | |
| 17110 | 5,324 | 4,282 | $848K | |
| 99223 | Prolong inpt eval add15 m | 14,496 | 13,248 | $845K |
| 31575 | 5,297 | 4,243 | $836K | |
| 97161 | 17,290 | 15,513 | $830K | |
| 31579 | 4,377 | 3,176 | $822K | |
| 64643 | 3,871 | 2,762 | $817K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 27,994 | 15,009 | $805K |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 1,269 | 392 | $803K |
| 83036 | Hemoglobin; glycosylated (A1C) | 101,129 | 89,244 | $780K |
| 71250 | 15,355 | 14,118 | $772K | |
| 76770 | 6,227 | 5,743 | $742K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 63,647 | 49,792 | $736K |
| 11900 | 3,517 | 2,802 | $727K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 83,006 | 71,519 | $715K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 2,516 | 2,314 | $710K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 40,726 | 37,225 | $710K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 7,734 | 6,286 | $706K |
| 97803 | 12,833 | 11,662 | $705K | |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | 8,991 | 2,731 | $689K |
| 90688 | 58,581 | 46,590 | $674K | |
| 88307 | 11,172 | 10,144 | $670K | |
| 90651 | 11,352 | 9,421 | $665K | |
| 86850 | 24,081 | 17,686 | $640K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 74,731 | 62,669 | $634K |
| J9173 | Injection, durvalumab, 10 mg | 74 | 40 | $625K |
| 92557 | 10,251 | 8,687 | $619K | |
| 94010 | 26,188 | 20,934 | $605K | |
| 93970 | 10,612 | 8,669 | $596K | |
| 70491 | 1,760 | 1,500 | $587K | |
| 99460 | 8,181 | 7,724 | $586K | |
| 73630 | 46,549 | 36,295 | $576K | |
| 84439 | 34,611 | 30,131 | $574K | |
| 97810 | 22,953 | 9,752 | $574K | |
| 64483 | 1,509 | 1,249 | $559K | |
| 76642 | 8,378 | 6,817 | $557K | |
| 93975 | 4,359 | 3,623 | $552K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 8,427 | 8,024 | $550K |
| 97535 | Self-care/home management training, each 15 minutes | 14,687 | 10,922 | $547K |
| 77300 | 1,032 | 873 | $540K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 10,505 | 10,134 | $538K |
| 99238 | Hospital discharge day management, 30 minutes or less | 19,247 | 18,008 | $535K |
| J0897 | Injection, denosumab, 1 mg | 1,030 | 837 | $517K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 2,558 | 2,300 | $509K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 3,458 | 3,090 | $508K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 905 | 559 | $508K |
| 92015 | Determination of refractive state | 41,698 | 34,594 | $506K |
| 77334 | 1,224 | 873 | $499K | |
| 85027 | 88,137 | 67,906 | $498K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 740 | 514 | $497K |
| 97802 | 6,817 | 5,902 | $493K | |
| 70498 | 1,868 | 1,598 | $477K | |
| 93308 | 5,602 | 4,800 | $474K | |
| 90837 | Psychotherapy, 53 minutes with patient | 3,602 | 2,482 | $470K |
| 96367 | 9,470 | 4,314 | $467K | |
| 91200 | 7,454 | 5,533 | $455K | |
| 38222 | 599 | 414 | $452K | |
| 92567 | 24,357 | 19,836 | $450K | |
| 51784 | 3,421 | 2,613 | $450K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 28,079 | 14,080 | $450K |
| 92587 | 5,945 | 4,839 | $445K | |
| 90750 | 2,287 | 1,962 | $444K | |
| 99349 | 16,847 | 14,713 | $439K | |
| 20611 | 1,458 | 1,110 | $437K | |
| 52310 | 595 | 549 | $437K | |
| 77301 | 571 | 508 | $436K | |
| J9022 | Injection, atezolizumab, 10 mg | 76 | 51 | $429K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 42,862 | 31,321 | $427K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,806 | 1,501 | $427K |
| 73564 | 35,200 | 26,653 | $425K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 49,379 | 34,493 | $425K |
| 76820 | 6,411 | 2,655 | $423K | |
| 87497 | 11,160 | 5,453 | $422K | |
| 97113 | 4,960 | 2,077 | $422K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 19,703 | 15,032 | $416K |
| 87481 | 41,287 | 34,518 | $412K | |
| 76536 | 4,631 | 4,030 | $410K | |
| 82728 | 29,382 | 24,592 | $408K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 2,792 | 2,392 | $408K |
| Q3014 | Telehealth originating site facility fee | 15,656 | 14,530 | $407K |
| 86780 | 28,401 | 23,974 | $407K | |
| 93451 | 348 | 274 | $407K | |
| 57454 | 1,168 | 1,013 | $385K | |
| 82607 | 25,800 | 21,994 | $378K | |
| 86803 | 28,432 | 23,800 | $374K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 58,022 | 48,531 | $371K |
| 80197 | 24,089 | 12,721 | $369K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 55,389 | 46,463 | $368K |
| 92083 | 12,914 | 9,300 | $365K | |
| 93017 | 3,819 | 3,241 | $353K | |
| 74018 | 49,827 | 39,091 | $347K | |
| 74183 | 1,599 | 1,427 | $340K | |
| 77412 | 1,984 | 293 | $338K | |
| 99239 | Hospital discharge day management, more than 30 minutes | 9,896 | 9,173 | $336K |
| 72197 | 1,117 | 987 | $334K | |
| 86900 | 24,819 | 17,843 | $333K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 13,632 | 11,830 | $331K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 7,583 | 7,232 | $328K |
| J0475 | Injection, baclofen, 10 mg | 972 | 861 | $327K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 4,036 | 3,665 | $321K |
| 91320 | 6,717 | 6,027 | $320K | |
| 95885 | 1,109 | 989 | $319K | |
| 86140 | 29,865 | 24,743 | $317K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 29,527 | 24,773 | $317K |
| 64405 | 841 | 672 | $316K | |
| 97811 | 22,915 | 9,733 | $313K | |
| 93971 | 4,898 | 4,125 | $309K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 14,563 | 8,057 | $308K |
| 19083 | 356 | 289 | $308K | |
| 77336 | 2,504 | 1,295 | $306K | |
| 58558 | 216 | 161 | $304K | |
| 93321 | 4,842 | 4,124 | $302K | |
| 84702 | 15,615 | 11,606 | $302K | |
| 87340 | 21,651 | 17,827 | $301K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 292 | 248 | $301K |
| 77295 | 353 | 269 | $301K | |
| 76821 | 3,957 | 1,731 | $299K | |
| 95117 | 8,959 | 4,473 | $296K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 31,107 | 26,541 | $293K |
| 77371 | 104 | 76 | $291K | |
| 73130 | 20,333 | 15,287 | $289K | |
| 64493 | 774 | 562 | $288K | |
| J0177 | Injection, aflibercept hd, 1 mg | 169 | 161 | $286K |
| 93454 | 266 | 204 | $284K | |
| 73030 | 22,289 | 18,571 | $284K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 54,902 | 46,868 | $284K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 49,823 | 43,537 | $283K |
| 76882 | 6,433 | 4,434 | $283K | |
| 94729 | 16,515 | 13,935 | $282K | |
| 73610 | 19,243 | 16,650 | $278K | |
| 52287 | 578 | 458 | $278K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 991 | 540 | $278K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 3,675 | 3,018 | $276K |
| 77373 | 305 | 100 | $268K | |
| 72100 | 14,561 | 13,243 | $266K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,715 | 1,587 | $265K |
| 83540 | 31,567 | 26,581 | $263K | |
| 58300 | 2,174 | 1,835 | $260K | |
| 94618 | 5,754 | 4,775 | $260K | |
| 20550 | 1,624 | 1,187 | $258K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 7,575 | 6,908 | $256K |
| 96900 | 6,914 | 1,595 | $248K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1,554 | 1,328 | $245K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 7,398 | 3,709 | $243K |
| 62323 | 553 | 460 | $243K | |
| 11721 | 12,948 | 8,689 | $243K | |
| 96416 | 1,690 | 734 | $241K | |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | 388 | 292 | $237K |
| 58100 | 1,390 | 1,182 | $233K | |
| 73221 | 973 | 885 | $233K | |
| 88141 | 11,042 | 10,628 | $230K | |
| 92133 | 10,005 | 7,685 | $230K | |
| 10005 | 601 | 527 | $230K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 664 | 386 | $229K |
| 90715 | 16,997 | 13,747 | $229K | |
| 83735 | 76,405 | 53,209 | $225K | |
| 93505 | 198 | 127 | $224K | |
| 93798 | 3,841 | 1,114 | $223K | |
| 25600 | 725 | 561 | $222K | |
| 01922 | 977 | 787 | $221K | |
| 99243 | 7,058 | 6,801 | $220K | |
| 93320 | 16,911 | 13,129 | $220K | |
| 98940 | 8,397 | 4,838 | $216K | |
| 83550 | 31,152 | 26,209 | $213K | |
| 36430 | 1,533 | 791 | $207K | |
| 84165 | 24,514 | 22,035 | $206K | |
| 64642 | 4,463 | 3,136 | $204K | |
| 10060 | 1,058 | 928 | $203K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 10,798 | 10,298 | $201K |
| 77338 | 602 | 525 | $201K | |
| 11056 | 2,485 | 1,639 | $200K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 16,292 | 13,372 | $197K |
| 87505 | 1,648 | 1,420 | $197K | |
| 76831 | 1,005 | 824 | $195K | |
| 86334 | 19,958 | 17,691 | $195K | |
| 72141 | 1,077 | 975 | $192K | |
| 86832 | 5,246 | 4,116 | $192K | |
| 97116 | 7,394 | 3,708 | $191K | |
| 55700 | 282 | 238 | $189K | |
| 86480 | 7,809 | 6,636 | $189K | |
| 83970 | 8,299 | 6,935 | $189K | |
| 95816 | 4,812 | 4,116 | $189K | |
| 93880 | 2,197 | 1,863 | $186K | |
| 73502 | 12,494 | 11,367 | $185K | |
| C1776 | Joint device (implantable) | 201 | 123 | $184K |
| C9290 | Injection, bupivacaine liposome, 1 mg | 1,581 | 1,169 | $183K |
| 97162 | 4,330 | 3,829 | $182K | |
| 83655 | 11,207 | 9,733 | $181K | |
| 95909 | 1,637 | 1,463 | $178K | |
| 96116 | 768 | 686 | $177K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 23,777 | 20,897 | $177K |
| 75561 | 586 | 488 | $175K | |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | 815 | 226 | $175K |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 5,205 | 3,914 | $174K |
| 86901 | 24,760 | 17,794 | $173K | |
| 85610 | 44,843 | 29,614 | $170K | |
| 82570 | 25,436 | 21,346 | $170K | |
| 92579 | 3,401 | 2,777 | $169K | |
| 86762 | 6,862 | 5,788 | $168K | |
| 95718 | 2,278 | 2,082 | $167K | |
| 85390 | 8,840 | 7,778 | $167K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 576 | 482 | $166K |
| 97165 | 2,581 | 2,122 | $166K | |
| 95012 | 3,363 | 2,986 | $166K | |
| J1756 | Injection, iron sucrose, 1 mg | 5,692 | 2,400 | $164K |
| 58301 | 1,597 | 1,420 | $163K | |
| 90832 | Psychotherapy, 30 minutes with patient | 2,397 | 1,769 | $162K |
| 95700 | 1,063 | 877 | $161K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 571 | 465 | $160K |
| 77470 | 462 | 400 | $159K | |
| J3490 | Unclassified drugs | 4,978 | 3,000 | $159K |
| 74178 | 577 | 512 | $158K | |
| 93226 | 1,197 | 1,078 | $158K | |
| 99254 | 2,547 | 2,395 | $158K | |
| 90480 | 8,935 | 8,095 | $157K | |
| 20526 | 636 | 512 | $156K | |
| P9045 | Infusion, albumin (human), 5%, 250 ml | 912 | 487 | $156K |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 619 | 532 | $154K |
| 12001 | 809 | 709 | $154K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 958 | 868 | $153K |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | 92 | 80 | $153K |
| Q5112 | Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg | 114 | 63 | $152K |
| 80069 | 10,535 | 7,469 | $151K | |
| 87510 | 11,104 | 10,308 | $151K | |
| 43249 | 377 | 303 | $151K | |
| 29075 | 994 | 828 | $150K | |
| 71271 | 1,321 | 1,208 | $148K | |
| 11982 | 657 | 578 | $148K | |
| 91120 | 2,468 | 1,850 | $147K | |
| J9306 | Injection, pertuzumab, 1 mg | 33 | 26 | $147K |
| 70486 | 1,544 | 1,331 | $147K | |
| 99462 | 4,741 | 4,068 | $147K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2,523 | 1,466 | $146K |
| 0124A | 5,676 | 3,668 | $146K | |
| 90670 | 20,077 | 17,356 | $146K | |
| 86706 | 11,164 | 9,136 | $145K | |
| 88342 | 10,491 | 9,093 | $144K | |
| 00731 | 8,672 | 6,640 | $142K | |
| 11981 | 620 | 520 | $138K | |
| 67228 | 420 | 340 | $138K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9,453 | 8,110 | $136K |
| 83880 | 16,125 | 12,667 | $136K | |
| 86038 | 7,988 | 6,470 | $134K | |
| 78264 | 646 | 586 | $132K | |
| 83020 | 10,528 | 9,199 | $130K | |
| 88341 | 2,372 | 1,879 | $129K | |
| 95076 | 620 | 540 | $128K | |
| 94726 | 3,983 | 3,401 | $127K | |
| 80076 | 10,418 | 8,645 | $126K | |
| 93922 | 2,600 | 2,194 | $126K | |
| 64612 | 424 | 342 | $124K | |
| 64616 | 469 | 384 | $123K | |
| 20552 | 1,055 | 827 | $123K | |
| 86833 | 5,335 | 4,111 | $122K | |
| 93296 | 5,924 | 5,681 | $122K | |
| 73110 | 7,196 | 6,026 | $122K | |
| J0586 | Injection, abobotulinumtoxina, 5 units | 174 | 112 | $121K |
| 95923 | 463 | 367 | $119K | |
| 91010 | 692 | 524 | $118K | |
| 77290 | 207 | 176 | $117K | |
| 99255 | 1,388 | 1,268 | $117K | |
| 91122 | 2,833 | 2,097 | $115K | |
| 82784 | 13,780 | 10,829 | $115K | |
| 90698 | 21,064 | 18,294 | $115K | |
| 95910 | 1,325 | 1,174 | $114K | |
| 78431 | 187 | 133 | $113K | |
| 72050 | 3,056 | 2,744 | $113K | |
| 81001 | 64,829 | 54,781 | $113K | |
| 90636 | 501 | 409 | $113K | |
| 87077 | 18,452 | 15,520 | $113K | |
| 99222 | Initial hospital care, per day, moderate complexity | 3,182 | 2,951 | $112K |
| 77049 | 291 | 275 | $111K | |
| 96156 | 695 | 612 | $110K | |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 130 | 50 | $110K |
| 95924 | 464 | 403 | $109K | |
| 69210 | 4,647 | 3,835 | $109K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 3,204 | 3,014 | $109K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 3,860 | 2,490 | $108K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 42,502 | 38,067 | $108K |
| 88112 | 7,673 | 6,944 | $107K | |
| 20600 | 629 | 513 | $107K | |
| 90620 | 2,699 | 2,241 | $107K | |
| 90945 | 3,258 | 957 | $107K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,261 | 949 | $106K |
| 90619 | 6,896 | 5,677 | $105K | |
| 84484 | 36,756 | 21,228 | $105K | |
| 17000 | 956 | 875 | $104K | |
| 86704 | 8,426 | 6,828 | $104K | |
| 92235 | 830 | 657 | $103K | |
| 95819 | 1,259 | 1,069 | $103K | |
| H1000 | Prenatal care, at-risk assessment | 794 | 707 | $103K |
| 70544 | 558 | 501 | $102K | |
| 92136 | 4,192 | 3,463 | $102K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 6,015 | 4,876 | $102K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 98 | 82 | $101K |
| 99205 | Prolong outpt/office vis | 2,104 | 1,973 | $101K |
| 30140 | 80 | 66 | $101K | |
| 86077 | 3,460 | 3,182 | $100K | |
| 70496 | 2,187 | 1,871 | $100K | |
| 93016 | 7,008 | 6,689 | $100K | |
| 84100 | 27,055 | 15,783 | $98K | |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 73 | 50 | $97K |
| 87799 | 6,997 | 4,568 | $97K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 8,198 | 4,973 | $97K |
| 99480 | Subsequent intensive care, per day, low birth weight infant | 1,323 | 466 | $97K |
| 99442 | 5,986 | 5,659 | $96K | |
| 0002A | 2,702 | 2,645 | $96K | |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 97 | 88 | $95K |
| 20605 | 539 | 432 | $95K | |
| 26600 | 261 | 220 | $94K | |
| 26720 | 276 | 223 | $94K | |
| 88184 | 1,208 | 877 | $94K | |
| 81455 | 268 | 198 | $93K | |
| 93225 | 1,358 | 1,136 | $93K | |
| 84403 | 6,774 | 5,864 | $93K | |
| 82977 | 9,227 | 5,304 | $93K | |
| 76512 | 997 | 795 | $93K | |
| 77080 | 1,840 | 1,603 | $92K | |
| 72156 | 967 | 836 | $91K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 752 | 459 | $91K |
| 66821 | 429 | 381 | $90K | |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | 415 | 123 | $90K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 450 | 426 | $90K |
| 17250 | 413 | 369 | $89K | |
| J9070 | Cyclophosphamide, 100 mg | 701 | 269 | $89K |
| 77062 | 2,078 | 1,883 | $88K | |
| J9041 | Injection, bortezomib, 0.1 mg | 2,209 | 514 | $87K |
| 84153 | 7,967 | 6,880 | $87K | |
| 50200 | 228 | 169 | $87K | |
| 97804 | 4,027 | 3,748 | $86K | |
| 87522 | Neg quan hep c or qual rna | 4,449 | 3,476 | $86K |
| 70546 | 447 | 389 | $86K | |
| 0001A | 2,924 | 2,771 | $85K | |
| 31237 | 163 | 123 | $85K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 37,145 | 29,329 | $85K |
| 87660 | 11,366 | 10,515 | $84K | |
| 12011 | 444 | 382 | $84K | |
| 94621 | 767 | 630 | $84K | |
| 99497 | 1,381 | 1,192 | $84K | |
| 76881 | 857 | 704 | $84K | |
| 99217 | 3,467 | 3,344 | $84K | |
| 87653 | 5,108 | 4,622 | $83K | |
| 82670 | 4,028 | 3,465 | $83K | |
| 11055 | 761 | 584 | $81K | |
| 17311 | 222 | 190 | $81K | |
| 64721 | 91 | 74 | $81K | |
| 74230 | 522 | 475 | $81K | |
| 97164 | 1,086 | 964 | $81K | |
| 20553 | 790 | 664 | $81K | |
| 99152 | 7,050 | 5,221 | $80K | |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 759 | 330 | $80K |
| 97166 | 1,332 | 1,153 | $80K | |
| 74174 | 1,049 | 834 | $80K | |
| 99306 | Prolong nursin fac eval 15m | 3,096 | 2,819 | $79K |
| 97155 | Adaptive behavior treatment with protocol modification, administered by physician, each 15 minutes | 964 | 458 | $79K |
| 84481 | 8,016 | 6,892 | $79K | |
| 90658 | 8,433 | 8,358 | $79K | |
| 73700 | 591 | 497 | $79K | |
| 82533 | 3,236 | 2,524 | $78K | |
| 94642 | 699 | 573 | $78K | |
| 88304 | 9,792 | 8,959 | $78K | |
| 90633 | 10,188 | 8,516 | $78K | |
| 73560 | 4,346 | 3,453 | $76K | |
| 76825 | 642 | 554 | $75K | |
| 93246 | 1,943 | 1,595 | $75K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,057 | 2,596 | $74K |
| 00104 | 1,963 | 1,163 | $73K | |
| 99253 | 1,804 | 1,634 | $73K | |
| 81370 | 616 | 489 | $73K | |
| 85652 | 23,769 | 20,109 | $71K | |
| 64450 | 446 | 366 | $71K | |
| 82043 | 15,175 | 13,208 | $71K | |
| 11983 | 183 | 155 | $71K | |
| 93799 | 8,383 | 2,498 | $71K | |
| 77061 | 1,567 | 1,401 | $70K | |
| 99245 | 974 | 926 | $70K | |
| 74160 | 435 | 368 | $70K | |
| 90716 | 4,821 | 4,031 | $68K | |
| P9047 | Infusion, albumin (human), 25%, 50 ml | 272 | 142 | $68K |
| 82805 | 2,671 | 1,694 | $68K | |
| 84146 | 4,240 | 3,620 | $67K | |
| 99397 | 738 | 642 | $67K | |
| 78816 | 75 | 66 | $66K | |
| 96130 | 1,579 | 1,252 | $66K | |
| C9257 | Injection, bevacizumab, 0.25 mg | 2,439 | 2,097 | $66K |
| 94660 | 778 | 342 | $66K | |
| 00811 | 4,389 | 3,402 | $66K | |
| 95911 | 730 | 654 | $65K | |
| 99406 | 2,582 | 2,344 | $65K | |
| 00142 | 4,853 | 3,424 | $65K | |
| 88346 | 1,412 | 1,147 | $65K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 238 | 159 | $64K |
| 86258 | 3,478 | 2,980 | $64K | |
| 99350 | Prolong home eval add 15m | 1,688 | 1,508 | $64K |
| 87493 | 1,859 | 1,595 | $64K | |
| 29405 | 421 | 301 | $63K | |
| 73140 | 3,127 | 2,762 | $63K | |
| 98927 | 2,111 | 1,398 | $63K | |
| 58340 | 1,022 | 838 | $62K | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 5,306 | 4,097 | $62K |
| 93990 | 1,594 | 1,197 | $61K | |
| 86364 | 4,893 | 4,162 | $61K | |
| 83001 | 4,441 | 3,806 | $61K | |
| 77014 | 2,286 | 749 | $61K | |
| 51728 | 311 | 281 | $60K | |
| 72131 | 746 | 646 | $60K | |
| 36514 | 67 | 13 | $60K | |
| 74240 | 335 | 304 | $59K | |
| 36589 | 186 | 162 | $59K | |
| 90686 | 8,239 | 6,851 | $59K | |
| 72158 | 408 | 348 | $58K | |
| 74019 | 1,621 | 1,444 | $58K | |
| 85396 | 5,469 | 2,842 | $58K | |
| 72110 | 1,640 | 1,477 | $58K | |
| 99443 | 2,787 | 2,627 | $57K | |
| 88185 | 1,208 | 872 | $57K | |
| 31624 | 125 | 87 | $57K | |
| 93923 | 1,082 | 977 | $57K | |
| 86003 | 3,528 | 2,936 | $56K | |
| 82627 | 2,861 | 2,464 | $55K | |
| 51798 | 7,898 | 6,893 | $55K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1,878 | 1,647 | $54K |
| 85060 | 4,840 | 4,216 | $54K | |
| 93660 | 495 | 407 | $54K | |
| 82746 | 9,420 | 7,900 | $54K | |
| 82962 | 34,773 | 15,760 | $53K | |
| 81003 | 61,868 | 52,496 | $53K | |
| 81206 | 347 | 282 | $53K | |
| 77065 | Tomosynthesis, mammo | 3,207 | 2,757 | $53K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1,626 | 847 | $52K |
| 45381 | 78 | 55 | $52K | |
| 82950 | 4,434 | 3,804 | $52K | |
| 76857 | 2,197 | 1,808 | $52K | |
| 82105 | 4,066 | 3,430 | $51K | |
| 90870 | 1,760 | 876 | $51K | |
| 99358 | Prolong nursin fac eval 15m | 338 | 322 | $51K |
| J9312 | Injection, rituximab, 10 mg | 25 | 16 | $51K |
| 70552 | 350 | 277 | $51K | |
| 90839 | 552 | 488 | $50K | |
| 86147 | 1,889 | 1,403 | $50K | |
| 81025 | 46,312 | 39,183 | $50K | |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 43 | 12 | $49K |
| 72040 | 1,461 | 1,303 | $49K | |
| 43248 | 141 | 123 | $49K | |
| 86431 | 5,057 | 4,227 | $49K | |
| 86376 | 3,206 | 2,669 | $49K | |
| 87186 | 14,116 | 12,035 | $49K | |
| 73562 | 1,541 | 1,320 | $48K | |
| 45330 | 103 | 79 | $48K | |
| 86160 | 4,426 | 3,474 | $48K | |
| 95992 | 570 | 401 | $48K | |
| 11750 | 121 | 91 | $48K | |
| 90680 | 12,730 | 11,126 | $48K | |
| 86359 | 2,360 | 1,847 | $47K | |
| 70543 | 131 | 115 | $47K | |
| 28470 | 152 | 132 | $47K | |
| 96523 | 1,049 | 682 | $46K | |
| 86235 | 4,370 | 3,324 | $46K | |
| 92025 | 1,032 | 868 | $46K | |
| 92524 | 573 | 479 | $46K | |
| 95115 | 1,320 | 648 | $46K | |
| 90746 | 2,615 | 2,014 | $46K | |
| 62369 | 1,742 | 908 | $45K | |
| 85018 | 8,466 | 6,935 | $45K | |
| 54161 | 32 | 31 | $45K | |
| 77066 | Tomosynthesis, mammo | 2,616 | 2,356 | $45K |
| 73590 | 2,292 | 1,882 | $45K | |
| 51705 | 870 | 703 | $44K | |
| 76514 | 1,097 | 903 | $44K | |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | 699 | 554 | $44K |
| 87536 | 1,937 | 1,577 | $44K | |
| 91112 | 255 | 180 | $44K | |
| 92250 | 1,283 | 1,173 | $44K | |
| 84402 | 2,850 | 2,451 | $43K | |
| 87070 | 7,734 | 6,232 | $43K | |
| 98926 | 1,394 | 903 | $43K | |
| 83615 | 9,528 | 6,747 | $43K | |
| 93018 | 5,049 | 4,830 | $43K | |
| 78306 | 332 | 293 | $42K | |
| 99153 | Mod sedat endo service >5yrs | 5,090 | 3,887 | $42K |
| 77370 | 532 | 422 | $42K | |
| 82525 | 3,488 | 2,865 | $42K | |
| 11100 | 209 | 102 | $41K | |
| 90697 | 4,981 | 4,748 | $41K | |
| 82024 | 1,404 | 1,146 | $41K | |
| 43762 | 255 | 234 | $41K | |
| 70480 | 261 | 234 | $41K | |
| 87640 | 1,965 | 1,599 | $41K | |
| 72082 | 1,320 | 1,228 | $41K | |
| 68840 | 103 | 89 | $40K | |
| 72157 | 528 | 454 | $40K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 36,903 | 20,883 | $40K |
| 88360 | 804 | 671 | $40K | |
| 76827 | 642 | 554 | $39K | |
| 73070 | 1,241 | 989 | $39K | |
| 92611 | 527 | 470 | $39K | |
| 84630 | 3,974 | 3,321 | $39K | |
| 19081 | 41 | 38 | $39K | |
| 86225 | 4,474 | 3,542 | $39K | |
| 84156 | 11,919 | 9,353 | $39K | |
| 96368 | 2,129 | 1,301 | $39K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 56 | 42 | $39K |
| 85576 | 1,626 | 1,188 | $38K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 2,067 | 907 | $38K |
| 99221 | 1,487 | 1,368 | $38K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 573 | 452 | $38K |
| 93926 | 656 | 571 | $37K | |
| 80502 | 1,338 | 1,107 | $37K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 100 | 81 | $37K |
| 27447 | 37 | 37 | $37K | |
| 88365 | 377 | 300 | $36K | |
| 86335 | 2,688 | 2,465 | $36K | |
| 90739 | 2,150 | 1,779 | $36K | |
| 88313 | 4,940 | 4,362 | $36K | |
| 81240 | 435 | 326 | $36K | |
| 86200 | 3,555 | 2,964 | $36K | |
| 83525 | 1,858 | 1,561 | $36K | |
| 81382 | 309 | 236 | $35K | |
| 90744 | 7,411 | 6,110 | $35K | |
| 51741 | 649 | 592 | $35K | |
| 92582 | 506 | 454 | $35K | |
| 73718 | 134 | 124 | $35K | |
| 93978 | 314 | 280 | $35K | |
| 90696 | 4,867 | 4,120 | $34K | |
| 73523 | 1,413 | 1,227 | $34K | |
| 72072 | 1,194 | 1,071 | $34K | |
| 83002 | 2,909 | 2,475 | $34K | |
| 88264 | 263 | 206 | $34K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 170 | 166 | $34K |
| 86256 | 3,483 | 2,863 | $34K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 3,488 | 2,898 | $34K |
| 73080 | 1,955 | 1,597 | $34K | |
| 72146 | 325 | 285 | $34K | |
| 81256 | 290 | 231 | $34K | |
| 92526 | 578 | 431 | $34K | |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 632 | 258 | $34K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,651 | 1,397 | $33K |
| C1874 | Stent, coated/covered, with delivery system | 144 | 97 | $33K |
| 82550 | 8,423 | 6,422 | $33K | |
| 84166 | 3,522 | 3,228 | $33K | |
| 31628 | 102 | 70 | $33K | |
| 85240 | 937 | 764 | $32K | |
| 82947 | 4,678 | 3,503 | $32K | |
| 84480 | 3,269 | 2,767 | $32K | |
| 86800 | 2,517 | 2,119 | $32K | |
| 83520 | 2,353 | 1,857 | $31K | |
| 73090 | 1,553 | 1,242 | $31K | |
| 97163 | 643 | 578 | $31K | |
| 83993 | 1,558 | 1,421 | $31K | |
| J1453 | Injection, fosaprepitant, 1 mg | 2,397 | 1,210 | $31K |
| J2997 | Injection, alteplase recombinant, 1 mg | 146 | 96 | $31K |
| 96146 | 287 | 258 | $31K | |
| 99417 | Prolong home eval add 15m | 441 | 413 | $30K |
| 96101 | 627 | 419 | $30K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 1,796 | 1,659 | $30K |
| 83521 | 4,770 | 3,681 | $30K | |
| J0640 | Injection, leucovorin calcium, per 50 mg | 1,356 | 544 | $30K |
| 84550 | 6,437 | 5,094 | $30K | |
| 90662 | 5,220 | 4,546 | $30K | |
| 62328 | 47 | 37 | $29K | |
| 87641 | 1,974 | 1,600 | $29K | |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 218 | 54 | $29K |
| 92553 | 371 | 337 | $29K | |
| 87902 | 183 | 151 | $29K | |
| J9035 | Injection, bevacizumab, 10 mg | 105 | 70 | $29K |
| 95024 | 685 | 579 | $29K | |
| 88311 | 4,685 | 4,253 | $28K | |
| 82785 | 2,686 | 2,237 | $28K | |
| 86923 | 978 | 615 | $28K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 270 | 195 | $28K |
| 36591 | 1,491 | 893 | $28K | |
| 88172 | 348 | 253 | $28K | |
| 88350 | 893 | 696 | $28K | |
| 99385 | 552 | 382 | $27K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 21,265 | 20,015 | $27K |
| 86870 | 797 | 595 | $27K | |
| 55250 | 20 | 13 | $27K | |
| 76818 | 239 | 193 | $27K | |
| 87517 | 958 | 694 | $27K | |
| 82330 | 3,971 | 2,636 | $27K | |
| 77427 | 288 | 150 | $27K | |
| 93312 | 158 | 120 | $27K | |
| 83690 | 19,746 | 15,858 | $27K | |
| 99464 | 386 | 372 | $27K | |
| 12002 | 160 | 137 | $27K | |
| 87529 | 2,237 | 1,872 | $27K | |
| 84425 | 3,064 | 2,652 | $26K | |
| 76937 | 1,308 | 939 | $26K | |
| 11103 | 528 | 468 | $26K | |
| 90461 | 19,581 | 17,368 | $26K | |
| 64415 | 49 | 41 | $26K | |
| 85730 | 11,269 | 7,808 | $26K | |
| 87480 | 11,110 | 10,313 | $25K | |
| 87205 | 7,280 | 5,786 | $25K | |
| 27786 | 80 | 71 | $25K | |
| 64644 | 576 | 507 | $25K | |
| 73100 | 567 | 448 | $25K | |
| 29065 | 153 | 123 | $25K | |
| 72070 | 820 | 716 | $25K | |
| 83516 | 1,849 | 1,198 | $25K | |
| 82565 | 4,138 | 3,472 | $25K | |
| 93298 | 1,218 | 1,167 | $25K | |
| 80074 | 2,700 | 2,250 | $25K | |
| 76870 | 925 | 783 | $24K | |
| 93750 | 2,012 | 1,254 | $24K | |
| 74270 | 173 | 147 | $24K | |
| 82951 | 937 | 856 | $24K | |
| 96401 | 2,782 | 1,178 | $24K | |
| 86787 | 2,185 | 1,824 | $24K | |
| 52356 | 16 | 12 | $23K | |
| 77072 | 543 | 496 | $23K | |
| 15275 | 105 | 25 | $23K | |
| 82103 | 2,357 | 1,798 | $23K | |
| 84207 | 2,355 | 1,928 | $23K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 885 | 804 | $23K |
| 85597 | 888 | 723 | $23K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 297 | 288 | $23K |
| 95912 | 357 | 313 | $22K | |
| J9074 | Injection, cyclophosphamide (sandoz), 5 mg | 69 | 40 | $22K |
| 92541 | 417 | 333 | $22K | |
| 84460 | 3,993 | 3,488 | $22K | |
| 81596 | 308 | 250 | $22K | |
| 66982 | 34 | 27 | $22K | |
| 82610 | 1,744 | 1,313 | $22K | |
| 84432 | 996 | 850 | $22K | |
| 86304 | 1,512 | 1,102 | $22K | |
| 86141 | 1,198 | 996 | $22K | |
| 84144 | 1,119 | 927 | $22K | |
| 99441 | 2,572 | 2,467 | $22K | |
| 31615 | 26 | 24 | $22K | |
| 29515 | 466 | 368 | $21K | |
| 86708 | 2,112 | 1,728 | $21K | |
| 95251 | 1,373 | 1,282 | $21K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 5,148 | 2,476 | $21K |
| 11440 | 53 | 42 | $21K | |
| 90710 | 5,038 | 4,247 | $21K | |
| 84155 | 5,391 | 4,191 | $21K | |
| 99220 | 394 | 368 | $21K | |
| 78582 | 32 | 25 | $21K | |
| 90961 | 544 | 515 | $21K | |
| 74021 | 549 | 506 | $21K | |
| 77280 | 154 | 118 | $21K | |
| 82088 | 934 | 728 | $21K | |
| 84450 | 3,309 | 2,908 | $20K | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | 3,283 | 3,012 | $20K |
| 90707 | 5,056 | 4,259 | $20K | |
| 73552 | 1,204 | 965 | $20K | |
| 99219 | 366 | 364 | $20K | |
| 93925 | 162 | 144 | $20K | |
| 86361 | 1,511 | 1,220 | $20K | |
| 91065 | 522 | 387 | $20K | |
| 86355 | 2,293 | 1,760 | $20K | |
| 86920 | 592 | 344 | $20K | |
| 10061 | 101 | 87 | $19K | |
| 86015 | 952 | 792 | $19K | |
| 96112 | 149 | 126 | $19K | |
| 97813 | 755 | 305 | $19K | |
| 11200 | 100 | 84 | $19K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 1,554 | 1,280 | $19K |
| 86765 | 1,900 | 1,581 | $19K | |
| 36573 | 15 | 13 | $19K | |
| 88237 | 353 | 270 | $19K | |
| 72200 | 589 | 526 | $19K | |
| 96376 | 6,472 | 3,568 | $19K | |
| 86039 | 2,010 | 1,621 | $19K | |
| 82248 | 2,561 | 2,036 | $18K | |
| 92652 | 398 | 344 | $18K | |
| 82274 | 890 | 813 | $18K | |
| 75574 | 86 | 73 | $18K | |
| 71101 | 1,076 | 963 | $18K | |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | 336 | 319 | $18K |
| 80324 | 1,871 | 1,640 | $18K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 161 | 121 | $18K |
| 87328 | 828 | 733 | $18K | |
| 82378 | 2,037 | 1,552 | $18K | |
| 87338 | 854 | 747 | $18K | |
| 92555 | 492 | 447 | $18K | |
| 86735 | 1,079 | 923 | $18K | |
| 99252 | 563 | 523 | $18K | |
| 84445 | 877 | 771 | $18K | |
| 86665 | 1,697 | 1,385 | $18K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 28 | 27 | $17K |
| 86308 | 1,144 | 947 | $17K | |
| 0004A | 519 | 502 | $17K | |
| 85045 | 6,168 | 4,283 | $17K | |
| 70355 | 488 | 398 | $17K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2,935 | 2,463 | $17K |
| 52332 | 15 | 12 | $17K | |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 127 | 76 | $17K |
| 86580 | 563 | 396 | $16K | |
| 86317 | 1,448 | 653 | $16K | |
| 69209 | 2,155 | 1,893 | $16K | |
| 95874 | 6,513 | 4,623 | $16K | |
| 86146 | 1,375 | 1,057 | $16K | |
| 86695 | 1,712 | 1,422 | $16K | |
| 30520 | 18 | 15 | $16K | |
| 83498 | 1,162 | 997 | $16K | |
| 76775 | 123 | 107 | $16K | |
| 83921 | 2,172 | 1,821 | $16K | |
| 82542 | 1,279 | 1,057 | $16K | |
| 80164 | 1,312 | 1,107 | $15K | |
| 0081A | 563 | 295 | $15K | |
| 46221 | 29 | 25 | $15K | |
| 78830 | 29 | 25 | $15K | |
| J9075 | Injection, cyclophosphamide, not otherwise specified, 5 mg | 93 | 73 | $15K |
| 92700 | 316 | 276 | $15K | |
| J9171 | Injection, docetaxel, 1 mg | 238 | 150 | $15K |
| 84305 | 863 | 747 | $15K | |
| 72170 | 917 | 747 | $15K | |
| 62321 | 27 | 26 | $15K | |
| 73000 | 391 | 333 | $15K | |
| 11402 | 26 | 25 | $15K | |
| 73200 | 96 | 81 | $15K | |
| 86644 | 1,062 | 804 | $14K | |
| 95044 | 40 | 25 | $14K | |
| 62370 | 293 | 269 | $14K | |
| 73060 | 846 | 691 | $14K | |
| 46600 | 1,235 | 1,066 | $14K | |
| 17003 | 531 | 482 | $14K | |
| 86301 | 1,186 | 916 | $14K | |
| 54150 | 369 | 330 | $14K | |
| 11720 | 408 | 386 | $14K | |
| 0054A | 787 | 711 | $14K | |
| 73660 | 767 | 686 | $14K | |
| 86036 | 1,012 | 821 | $14K | |
| 99471 | 26 | 26 | $14K | |
| 99386 | 240 | 164 | $14K | |
| 80175 | 910 | 784 | $13K | |
| 51720 | 50 | 27 | $13K | |
| J3489 | Injection, zoledronic acid, 1 mg | 816 | 668 | $13K |
| 86696 | 1,697 | 1,409 | $13K | |
| 92556 | 335 | 305 | $13K | |
| 96131 | 365 | 324 | $13K | |
| 00300 | 724 | 539 | $13K | |
| 0154A | 350 | 286 | $13K | |
| 84681 | 1,089 | 885 | $13K | |
| G0426 | Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | 179 | 170 | $13K |
| 57456 | 33 | 25 | $13K | |
| 84244 | 876 | 717 | $13K | |
| 77085 | 277 | 250 | $13K | |
| 86341 | 977 | 752 | $13K | |
| 80177 | 1,406 | 1,163 | $13K | |
| 71555 | 81 | 68 | $13K | |
| 82952 | 782 | 712 | $13K | |
| 94799 | 694 | 362 | $13K | |
| 99348 | 644 | 579 | $13K | |
| 81332 | 389 | 301 | $13K | |
| 77387 | 248 | 40 | $13K | |
| 82390 | 1,306 | 1,045 | $13K | |
| 99242 | 527 | 515 | $12K | |
| 72128 | 262 | 221 | $12K | |
| 92546 | 154 | 120 | $12K | |
| 92552 | 187 | 173 | $12K | |
| 84154 | 1,326 | 1,158 | $12K | |
| 0071A | 422 | 328 | $12K | |
| 23500 | 34 | 27 | $12K | |
| 93295 | 434 | 417 | $12K | |
| 00840 | 725 | 505 | $12K | |
| 51700 | 224 | 191 | $12K | |
| 82040 | 1,823 | 1,568 | $12K | |
| 93351 | 712 | 626 | $11K | |
| 83010 | 1,498 | 1,088 | $11K | |
| J9206 | Injection, irinotecan, 20 mg | 1,040 | 358 | $11K |
| 43237 | 29 | 26 | $11K | |
| 0402T | 16 | 13 | $11K | |
| 97814 | 754 | 304 | $11K | |
| 80158 | 741 | 377 | $11K | |
| J2704 | Injection, propofol, 10 mg | 33,447 | 22,915 | $11K |
| 80323 | 1,327 | 1,059 | $11K | |
| 84163 | 418 | 373 | $11K | |
| 82653 | 515 | 464 | $11K | |
| 82150 | 2,496 | 1,999 | $11K | |
| 84270 | 709 | 614 | $11K | |
| 86381 | 873 | 716 | $11K | |
| 95018 | 347 | 302 | $11K | |
| 85041 | 2,301 | 1,902 | $11K | |
| J9395 | Injection, fulvestrant, 25 mg | 99 | 75 | $10K |
| J9323 | Injection, pemetrexed ditromethamine, 10 mg | 93 | 25 | $10K |
| 0082A | 343 | 225 | $10K | |
| J9045 | Injection, carboplatin, 50 mg | 1,356 | 772 | $10K |
| 00140 | 815 | 662 | $10K | |
| 92523 | 294 | 260 | $10K | |
| 81268 | 45 | 36 | $10K | |
| 88312 | 991 | 866 | $10K | |
| 80348 | 1,902 | 1,666 | $10K | |
| 84436 | 936 | 796 | $10K | |
| 82397 | 796 | 566 | $10K | |
| 80361 | 1,870 | 1,640 | $10K | |
| 80365 | 1,969 | 1,727 | $10K | |
| 86255 | 1,325 | 840 | $10K | |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 815 | 316 | $10K |
| 76942 | 1,732 | 1,394 | $10K | |
| 80373 | 1,870 | 1,640 | $10K | |
| 90474 | 2,234 | 1,795 | $10K | |
| 92626 | 135 | 121 | $10K | |
| 51600 | 209 | 169 | $10K | |
| 92550 | 228 | 157 | $10K | |
| 90632 | 459 | 394 | $10K | |
| 83605 | 7,688 | 5,016 | $10K | |
| 93985 | 142 | 125 | $10K | |
| 27130 | 13 | 12 | $9K | |
| 96402 | 1,255 | 992 | $9K | |
| 86705 | 693 | 577 | $9K | |
| 83721 | 1,645 | 1,439 | $9K | |
| 86618 | 879 | 735 | $9K | |
| 86664 | 667 | 548 | $9K | |
| 85379 | 5,059 | 4,145 | $9K | |
| 80354 | 1,870 | 1,640 | $9K | |
| 80349 | 1,870 | 1,640 | $9K | |
| 84132 | 3,773 | 2,671 | $9K | |
| 70487 | 29 | 29 | $9K | |
| 90785 | 978 | 678 | $9K | |
| 75565 | 645 | 552 | $9K | |
| 51797 | 498 | 453 | $9K | |
| 86300 | 531 | 419 | $9K | |
| 00813 | 2,692 | 2,094 | $9K | |
| 64447 | 54 | 40 | $9K | |
| J3470 | Injection, hyaluronidase, up to 150 units | 684 | 543 | $9K |
| 87040 | 4,636 | 2,282 | $9K | |
| 80356 | 1,858 | 1,628 | $9K | |
| 92545 | 276 | 218 | $9K | |
| 80353 | 1,871 | 1,640 | $9K | |
| 86880 | 515 | 411 | $9K | |
| 82085 | 897 | 747 | $9K | |
| 87329 | 822 | 732 | $9K | |
| 86922 | 424 | 243 | $8K | |
| 92285 | 203 | 159 | $8K | |
| 90685 | 1,569 | 1,324 | $8K | |
| 80178 | 567 | 442 | $8K | |
| J9263 | Injection, oxaliplatin, 0.5 mg | 961 | 410 | $8K |
| 00145 | 523 | 440 | $8K | |
| 36471 | 12 | 12 | $8K | |
| 80364 | 1,870 | 1,640 | $8K | |
| 80358 | 1,871 | 1,640 | $8K | |
| 86592 | 1,574 | 1,263 | $8K | |
| 0072A | 277 | 236 | $8K | |
| 00520 | 887 | 662 | $8K | |
| 11980 | 26 | 24 | $8K | |
| 77075 | 78 | 66 | $8K | |
| 87177 | 374 | 327 | $8K | |
| 92060 | 661 | 584 | $8K | |
| 96132 | 779 | 697 | $8K | |
| 82652 | 899 | 769 | $8K | |
| 84590 | 1,169 | 960 | $8K | |
| 82164 | 692 | 574 | $8K | |
| G0452 | Molecular pathology procedure; physician interpretation and report | 909 | 820 | $8K |
| 76883 | 59 | 52 | $8K | |
| 82310 | 956 | 810 | $8K | |
| 47000 | 18 | 12 | $8K | |
| 92519 | 37 | 31 | $8K | |
| 83835 | 527 | 442 | $8K | |
| 87015 | 1,318 | 1,012 | $8K | |
| 82232 | 666 | 510 | $8K | |
| 93000 | 521 | 502 | $8K | |
| 96152 | 214 | 158 | $8K | |
| A9270 | Non-covered item or service | 8,875 | 4,502 | $8K |
| 96158 | 300 | 266 | $8K | |
| 83695 | 861 | 736 | $8K | |
| 82677 | 237 | 209 | $8K | |
| 64494 | 688 | 471 | $8K | |
| 70250 | 244 | 190 | $8K | |
| 92542 | 317 | 238 | $8K | |
| 97597 | 189 | 81 | $8K | |
| 96136 | 883 | 786 | $7K | |
| 86921 | 389 | 215 | $7K | |
| 86357 | 807 | 595 | $7K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 59 | 36 | $7K |
| 99383 | 145 | 133 | $7K | |
| 74220 | 168 | 164 | $7K | |
| 72220 | 347 | 310 | $7K | |
| 84134 | 769 | 645 | $7K | |
| 29125 | 429 | 372 | $7K | |
| 80299 | 431 | 340 | $7K | |
| 51702 | 573 | 467 | $7K | |
| J1815 | Injection, insulin, per 5 units | 678 | 440 | $7K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 288 | 230 | $7K |
| 86360 | 788 | 585 | $7K | |
| 87102 | 1,762 | 1,396 | $7K | |
| 0298T | 117 | 115 | $7K | |
| 36226 | 15 | 12 | $7K | |
| 93976 | 55 | 40 | $7K | |
| 20551 | 32 | 25 | $7K | |
| 99305 | 347 | 311 | $7K | |
| 99201 | 692 | 682 | $7K | |
| 82077 | 4,612 | 3,478 | $7K | |
| 85520 | 1,333 | 1,049 | $7K | |
| 77293 | 53 | 52 | $7K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 2,496 | 1,296 | $7K |
| 0051A | 282 | 175 | $7K | |
| C1760 | Closure device, vascular (implantable/insertable) | 612 | 420 | $7K |
| 76604 | 94 | 81 | $6K | |
| 83519 | 609 | 473 | $6K | |
| 88142 | 1,234 | 1,125 | $6K | |
| 87088 | 1,871 | 1,697 | $6K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 495 | 463 | $6K |
| 90966 | 65 | 63 | $6K | |
| 93248 | 363 | 357 | $6K | |
| 12032 | 307 | 274 | $6K | |
| 87563 | 479 | 413 | $6K | |
| 88173 | 1,206 | 1,010 | $6K | |
| Q5121 | Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | 14 | 12 | $6K |
| 99421 | 684 | 663 | $6K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20,076 | 16,713 | $6K |
| 73522 | 153 | 134 | $6K | |
| 81479 | Unlisted molecular pathology procedure | 89 | 74 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 23,708 | 19,198 | $6K |
| 84466 | 880 | 732 | $6K | |
| 82340 | 531 | 445 | $6K | |
| 89051 | 2,339 | 1,521 | $6K | |
| 80235 | 623 | 528 | $6K | |
| 92082 | 123 | 110 | $6K | |
| 77091 | 276 | 265 | $6K | |
| 88291 | 695 | 575 | $6K | |
| 80143 | 1,036 | 775 | $6K | |
| 84446 | 890 | 723 | $6K | |
| 90648 | 930 | 754 | $5K | |
| 94681 | 147 | 89 | $5K | |
| 82180 | 567 | 469 | $5K | |
| 00790 | 363 | 254 | $5K | |
| 64999 | 44 | 37 | $5K | |
| 83090 | 1,113 | 927 | $5K | |
| 74221 | 31 | 27 | $5K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 28 | 28 | $5K |
| 90678 | 755 | 707 | $5K | |
| 82175 | 388 | 296 | $5K | |
| 84080 | 720 | 621 | $5K | |
| 99307 | 695 | 459 | $5K | |
| 36600 | 808 | 630 | $5K | |
| 85014 | 999 | 820 | $5K | |
| 28490 | 13 | 12 | $5K | |
| 80203 | 579 | 480 | $5K | |
| 82668 | 448 | 360 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 152 | 150 | $5K |
| 80346 | 579 | 470 | $5K | |
| 00400 | 970 | 697 | $5K | |
| 93280 | 617 | 550 | $5K | |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 25 | 14 | $5K |
| 80321 | 642 | 465 | $5K | |
| 85384 | 1,324 | 868 | $5K | |
| 0052A | 211 | 163 | $5K | |
| 81374 | 31 | 25 | $5K | |
| 26750 | 14 | 12 | $5K | |
| 93284 | 362 | 292 | $5K | |
| 82247 | 1,192 | 859 | $5K | |
| 73521 | 152 | 146 | $5K | |
| 82140 | 629 | 530 | $5K | |
| 97032 | 353 | 181 | $5K | |
| 94664 | 474 | 429 | $5K | |
| 86593 | 535 | 448 | $5K | |
| 88331 | 82 | 66 | $5K | |
| 30901 | 114 | 93 | $4K | |
| 80047 | 593 | 335 | $4K | |
| 70360 | 282 | 236 | $4K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 7,381 | 5,162 | $4K |
| 80183 | 420 | 358 | $4K | |
| 86703 | 2,365 | 1,982 | $4K | |
| 90681 | 578 | 512 | $4K | |
| C1883 | Adapter/extension, pacing lead or neurostimulator lead (implantable) | 64 | 39 | $4K |
| 85613 | 1,483 | 728 | $4K | |
| 93356 | 566 | 455 | $4K | |
| 73650 | 133 | 97 | $4K | |
| 90700 | 780 | 644 | $4K | |
| 83013 | 80 | 69 | $4K | |
| 93299 | 158 | 151 | $4K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 2,046 | 1,534 | $4K |
| 01961 | 13 | 13 | $4K | |
| 95712 | 42 | 38 | $4K | |
| 87206 | 1,354 | 1,069 | $4K | |
| 75635 | 12 | 12 | $4K | |
| 97750 | 45 | 37 | $4K | |
| G0008 | Administration of influenza virus vaccine | 6,509 | 5,614 | $4K |
| 85598 | 624 | 530 | $4K | |
| 90732 | 359 | 248 | $4K | |
| 88300 | 1,432 | 1,188 | $4K | |
| 82495 | 340 | 282 | $4K | |
| 74712 | 17 | 12 | $4K | |
| 86677 | 494 | 393 | $4K | |
| 84238 | 233 | 182 | $4K | |
| 86709 | 547 | 453 | $4K | |
| 00120 | 203 | 148 | $4K | |
| J9000 | Injection, doxorubicin hydrochloride, 10 mg | 513 | 240 | $4K |
| 84703 | 3,438 | 3,045 | $4K | |
| 69200 | 210 | 180 | $4K | |
| 64495 | 261 | 172 | $4K | |
| 93793 | 1,040 | 585 | $4K | |
| 80201 | 277 | 241 | $4K | |
| 87209 | 350 | 308 | $4K | |
| 84075 | 832 | 691 | $4K | |
| 82787 | 437 | 359 | $4K | |
| 98928 | 163 | 131 | $4K | |
| 85670 | 1,193 | 976 | $4K | |
| J9060 | Injection, cisplatin, powder or solution, 10 mg | 336 | 104 | $4K |
| 92597 | 72 | 62 | $4K | |
| 83825 | 516 | 387 | $4K | |
| 77002 | 320 | 275 | $4K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 6,166 | 3,048 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,072 | 2,736 | $4K |
| 87116 | 1,050 | 793 | $4K | |
| 99195 | 112 | 81 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 438 | 426 | $3K |
| 86828 | 520 | 428 | $3K | |
| 82523 | 374 | 340 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | 8,988 | 3,413 | $3K |
| 86682 | 370 | 313 | $3K | |
| 11901 | 14 | 12 | $3K | |
| 99173 | 1,499 | 1,420 | $3K | |
| 00160 | 531 | 417 | $3K | |
| 87507 | 97 | 84 | $3K | |
| 90734 | 553 | 381 | $3K | |
| 77074 | 147 | 120 | $3K | |
| 92341 | 173 | 135 | $3K | |
| 0003A | 87 | 80 | $3K | |
| 99236 | Prolong inpt eval add15 m | 53 | 50 | $3K |
| 92504 | 2,342 | 1,760 | $3K | |
| 96137 | 238 | 224 | $3K | |
| 36592 | 150 | 87 | $3K | |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 29 | 12 | $3K |
| 96118 | 22 | 12 | $3K | |
| 29425 | 15 | 14 | $3K | |
| 76377 | 2,296 | 2,039 | $3K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 410 | 321 | $3K |
| 11730 | 32 | 25 | $3K | |
| 93227 | 142 | 137 | $3K | |
| 87101 | 488 | 425 | $3K | |
| 82803 | 1,803 | 1,406 | $3K | |
| 83630 | 142 | 122 | $3K | |
| 82375 | 1,692 | 1,021 | $3K | |
| 93458 | 29 | 29 | $3K | |
| 90656 | 362 | 357 | $3K | |
| 95079 | 15 | 12 | $3K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,558 | 911 | $3K |
| 98929 | 55 | 54 | $3K | |
| 92020 | 424 | 412 | $3K | |
| 80179 | 945 | 719 | $3K | |
| 77077 | 141 | 132 | $3K | |
| 86008 | 411 | 353 | $3K | |
| 81002 | 4,065 | 3,506 | $3K | |
| 92604 | 176 | 128 | $3K | |
| J1611 | Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg | 69 | 63 | $3K |
| 92242 | 12 | 12 | $3K | |
| 82010 | 1,323 | 1,042 | $3K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 24,207 | 18,124 | $3K |
| 77073 | 123 | 113 | $3K | |
| 76506 | 94 | 67 | $3K | |
| 74150 | 17 | 13 | $2K | |
| 12031 | 41 | 39 | $2K | |
| 84145 | 687 | 537 | $2K | |
| 00812 | 969 | 774 | $2K | |
| 95908 | 14 | 14 | $2K | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 1,371 | 830 | $2K |
| 90962 | 87 | 79 | $2K | |
| 87486 | 277 | 196 | $2K | |
| 93283 | 265 | 234 | $2K | |
| 84478 | 369 | 282 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 30,061 | 21,332 | $2K |
| D1208 | Topical application of fluoride, excluding varnish | 164 | 153 | $2K |
| C1781 | Mesh (implantable) | 93 | 68 | $2K |
| J0485 | Injection, belatacept, 1 mg | 26 | 12 | $2K |
| 85046 | 383 | 335 | $2K | |
| 93319 | 47 | 38 | $2K | |
| 90714 | 158 | 133 | $2K | |
| 93282 | 159 | 138 | $2K | |
| C1889 | Implantable/insertable device, not otherwise classified | 781 | 660 | $2K |
| 97129 | 88 | 50 | $2K | |
| 82530 | 105 | 94 | $2K | |
| 86777 | 152 | 119 | $2K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 3,160 | 2,419 | $2K |
| 94070 | 13 | 13 | $2K | |
| 96111 | 64 | 61 | $2K | |
| 84300 | 517 | 421 | $2K | |
| 82166 | 127 | 112 | $2K | |
| 88189 | 53 | 46 | $2K | |
| 96417 | 3,925 | 2,088 | $2K | |
| 92132 | 98 | 82 | $2K | |
| 83785 | 291 | 243 | $2K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 685 | 646 | $2K |
| 74022 | 331 | 291 | $2K | |
| 00320 | 469 | 317 | $2K | |
| 83021 | 164 | 142 | $2K | |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 21 | 13 | $2K |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 2,181 | 1,510 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 28,225 | 17,978 | $2K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 1,282 | 880 | $2K |
| 82365 | 303 | 263 | $2K | |
| J2800 | Injection, methocarbamol, up to 10 ml | 717 | 237 | $2K |
| C9113 | Injection, pantoprazole sodium, per vial | 1,050 | 542 | $2K |
| 92610 | 46 | 39 | $2K | |
| 85732 | 468 | 356 | $2K | |
| 88302 | 207 | 169 | $2K | |
| 85307 | 276 | 216 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 33,834 | 23,842 | $2K |
| 73600 | 68 | 62 | $2K | |
| 87900 | 16 | 12 | $2K | |
| 85097 | 57 | 53 | $2K | |
| 88271 | 20 | 13 | $2K | |
| 88177 | 472 | 233 | $2K | |
| 84182 | 123 | 102 | $2K | |
| 80320 | 279 | 197 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3,590 | 2,334 | $2K |
| 84252 | 229 | 186 | $2K | |
| 99384 | 24 | 24 | $2K | |
| 96150 | 32 | 26 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 5,801 | 3,880 | $2K |
| 80500 | 276 | 205 | $2K | |
| 83883 | 134 | 122 | $2K | |
| 82384 | 55 | 39 | $2K | |
| 90713 | 337 | 287 | $2K | |
| 87581 | 289 | 204 | $2K | |
| 84295 | 1,892 | 1,239 | $2K | |
| 84520 | 693 | 498 | $2K | |
| 77263 | 25 | 24 | $2K | |
| 82671 | 114 | 104 | $2K | |
| 82553 | 240 | 150 | $2K | |
| 00902 | 387 | 301 | $2K | |
| 72052 | 27 | 24 | $1K | |
| 99292 | 32 | 15 | $1K | |
| 94760 | 12,322 | 7,031 | $1K | |
| 0083A | 87 | 34 | $1K | |
| 99495 | 391 | 367 | $1K | |
| 87081 | 232 | 203 | $1K | |
| 77001 | 229 | 171 | $1K | |
| 82379 | 256 | 212 | $1K | |
| 36620 | 258 | 230 | $1K | |
| 81329 | 15 | 13 | $1K | |
| 83789 | 142 | 107 | $1K | |
| 96409 | 498 | 201 | $1K | |
| 82104 | 203 | 157 | $1K | |
| 00537 | 45 | 36 | $1K | |
| 96133 | 711 | 639 | $1K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1,241 | 1,073 | $1K |
| J3535 | Drug administered through a metered dose inhaler | 95 | 56 | $1K |
| 00910 | 334 | 274 | $1K | |
| 82139 | 135 | 107 | $1K | |
| V2020 | Frames, purchases | 150 | 147 | $1K |
| 01810 | 334 | 257 | $1K | |
| 86336 | 229 | 201 | $1K | |
| 36556 | 101 | 89 | $1K | |
| 82955 | 105 | 92 | $1K | |
| 85245 | 57 | 51 | $1K | |
| J1071 | Injection, testosterone cypionate, 1 mg | 416 | 196 | $1K |
| 01920 | 21 | 13 | $1K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 9,912 | 6,173 | $1K |
| 87109 | 226 | 193 | $1K | |
| 87210 | 517 | 384 | $1K | |
| 01480 | 162 | 111 | $1K | |
| 85246 | 61 | 53 | $1K | |
| 00940 | 121 | 73 | $1K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 3,591 | 2,644 | $1K |
| 99218 | 33 | 30 | $1K | |
| 99459 | 32 | 32 | $1K | |
| 11105 | 928 | 698 | $1K | |
| 83050 | 1,765 | 897 | $1K | |
| 01844 | 38 | 27 | $1K | |
| 94761 | 1,332 | 1,169 | $1K | |
| 85660 | 293 | 244 | $1K | |
| 88377 | 82 | 56 | $1K | |
| 51701 | 101 | 92 | $1K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 9,289 | 8,093 | $1K |
| 84433 | 157 | 131 | $992.29 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 6,168 | 4,249 | $992.18 |
| 92002 | 31 | 27 | $987.69 | |
| 80165 | 118 | 100 | $979.40 | |
| 85300 | 302 | 238 | $957.50 | |
| 86825 | 13 | 13 | $928.17 | |
| 99483 | Prolong outpt/office vis | 59 | 57 | $926.79 |
| 86053 | 88 | 76 | $917.21 | |
| 82747 | 124 | 105 | $914.61 | |
| 97763 | 13 | 12 | $898.85 | |
| 99310 | Prolong nursin fac eval 15m | 37 | 29 | $894.45 |
| 88344 | 15 | 12 | $887.30 | |
| 00920 | 466 | 401 | $880.11 | |
| J7050 | Infusion, normal saline solution, 250 cc | 17,320 | 10,192 | $878.87 |
| 84479 | 158 | 138 | $877.09 | |
| 80195 | 105 | 62 | $869.50 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 37,510 | 23,959 | $849.50 |
| J2785 | Injection, regadenoson, 0.1 mg | 1,848 | 1,474 | $836.23 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 630 | 430 | $829.82 |
| 87324 | 71 | 60 | $822.27 | |
| 78492 | 16 | 13 | $820.40 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 17,375 | 11,723 | $806.20 |
| 96103 | 101 | 94 | $805.87 | |
| 96153 | 79 | 41 | $797.84 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 66 | 61 | $794.20 |
| 99225 | 60 | 39 | $793.95 | |
| 98968 | 209 | 189 | $787.81 | |
| 87220 | 275 | 224 | $783.35 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 3,244 | 1,781 | $775.72 |
| 11719 | 47 | 27 | $755.18 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 1,131 | 758 | $751.41 |
| 80377 | 30 | 30 | $747.65 | |
| 86041 | 134 | 116 | $746.15 | |
| 96139 | 737 | 665 | $743.62 | |
| 85303 | 281 | 226 | $738.21 | |
| 87075 | 630 | 492 | $737.29 | |
| 85306 | 263 | 213 | $725.27 | |
| 87106 | 226 | 192 | $723.76 | |
| 83935 | 151 | 124 | $717.80 | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 69 | 67 | $711.61 |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 622 | 542 | $699.53 |
| 59430 | 13 | 12 | $696.28 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 812 | 645 | $688.25 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 809 | 678 | $680.99 |
| C1769 | Guide wire | 3,222 | 2,494 | $680.53 |
| 88720 | 3,035 | 2,147 | $659.69 | |
| 80230 | 130 | 103 | $652.49 | |
| 36416 | 5,320 | 3,879 | $638.26 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 2,162 | 1,794 | $637.14 |
| 86316 | 64 | 45 | $630.31 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 29,252 | 20,612 | $627.45 |
| 93244 | 38 | 37 | $627.03 | |
| 74328 | 25 | 25 | $624.52 | |
| 89060 | 345 | 295 | $597.95 | |
| 76376 | 173 | 150 | $596.03 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 1,136 | 1,021 | $591.83 |
| 99241 | 43 | 42 | $589.10 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,763 | 949 | $588.63 |
| 76098 | 15 | 13 | $583.88 | |
| 99226 | 17 | 14 | $556.05 | |
| 86363 | 92 | 77 | $555.29 | |
| 80185 | 73 | 62 | $550.26 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 2,362 | 1,579 | $543.39 |
| 00126 | 704 | 600 | $542.39 | |
| 83930 | 145 | 118 | $540.08 | |
| 0064A | 19 | 19 | $539.52 | |
| 64646 | 27 | 24 | $532.99 | |
| 86808 | 38 | 29 | $514.34 | |
| 96910 | 18 | 14 | $495.06 | |
| 86645 | 36 | 26 | $492.80 | |
| 87305 | 91 | 58 | $492.38 | |
| 0399T | 15 | 13 | $489.81 | |
| 90723 | 181 | 143 | $488.50 | |
| 84210 | 95 | 67 | $487.39 | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 165 | 158 | $481.15 |
| 83986 | 144 | 110 | $478.67 | |
| 86060 | 22 | 15 | $476.16 | |
| J0461 | Injection, atropine sulfate, 0.01 mg | 390 | 237 | $474.57 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 7,148 | 4,144 | $472.94 |
| 87341 | 75 | 65 | $468.77 | |
| C1830 | Powered bone marrow biopsy needle | 518 | 378 | $467.58 |
| 99345 | Prolong home eval add 15m | 13 | 13 | $464.76 |
| 87176 | 463 | 328 | $460.60 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 1,004 | 902 | $454.48 |
| 99354 | 14 | 12 | $453.16 | |
| 83918 | 49 | 41 | $452.58 | |
| 93042 | 251 | 232 | $437.78 | |
| 01470 | 19 | 13 | $435.37 | |
| 86753 | 43 | 29 | $431.45 | |
| 00732 | 112 | 75 | $428.85 | |
| J0834 | Injection, cosyntropin, 0.25 mg | 19 | 12 | $425.92 |
| J9181 | Injection, etoposide, 10 mg | 95 | 27 | $417.42 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,304 | 970 | $415.49 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 10,388 | 6,242 | $408.73 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 1,833 | 1,312 | $401.70 |
| 85049 | 173 | 129 | $398.16 | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 25 | 16 | $397.25 |
| 96377 | 698 | 462 | $395.31 | |
| 80162 | 37 | 25 | $389.86 | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 12 | 12 | $384.40 |
| G0009 | Administration of pneumococcal vaccine | 1,845 | 1,546 | $384.32 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 1,268 | 713 | $381.82 |
| 96138 | 737 | 665 | $378.73 | |
| 86687 | 38 | 25 | $369.76 | |
| 82945 | 516 | 390 | $365.26 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 2,550 | 1,731 | $359.05 |
| 83014 | 25 | 24 | $356.52 | |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | 103 | 94 | $356.07 |
| 80169 | 15 | 12 | $356.06 | |
| 87154 | 12 | 12 | $355.98 | |
| 01830 | 170 | 124 | $351.00 | |
| 62252 | 63 | 50 | $349.87 | |
| 95822 | 33 | 30 | $343.61 | |
| 82172 | 14 | 12 | $336.42 | |
| 29130 | 14 | 12 | $334.32 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 1,103 | 847 | $332.46 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 579 | 411 | $329.43 |
| 87184 | 192 | 149 | $322.73 | |
| J1940 | Injection, furosemide, up to 20 mg | 2,136 | 1,110 | $322.24 |
| 36410 | 82 | 69 | $321.99 | |
| 99496 | 129 | 121 | $321.36 | |
| 0031A | 13 | 12 | $315.13 | |
| 92226 | 27 | 27 | $303.81 | |
| 93261 | 15 | 14 | $303.51 | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 518 | 392 | $298.51 |
| 84255 | 59 | 54 | $294.87 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 199 | 176 | $289.30 |
| 84157 | 654 | 488 | $284.84 | |
| A9540 | Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries | 169 | 135 | $283.58 |
| 87147 | 126 | 109 | $275.30 | |
| 86606 | 31 | 26 | $274.53 | |
| 95249 | 32 | 31 | $272.48 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 515 | 396 | $269.39 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 2,341 | 1,748 | $268.54 |
| 85247 | 24 | 24 | $262.35 | |
| A4648 | Tissue marker, implantable, any type, each | 801 | 629 | $261.27 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 5,547 | 3,143 | $259.42 |
| 93294 | 25 | 25 | $259.07 | |
| 73620 | 52 | 25 | $252.16 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 2,007 | 1,727 | $248.32 |
| J3360 | Injection, diazepam, up to 5 mg | 433 | 330 | $246.98 |
| J1790 | Injection, droperidol, up to 5 mg | 2,949 | 2,246 | $238.72 |
| 77081 | 16 | 14 | $235.40 | |
| 99251 | 12 | 12 | $231.10 | |
| 93228 | 12 | 12 | $228.75 | |
| 86596 | 54 | 41 | $227.86 | |
| J2720 | Injection, protamine sulfate, per 10 mg | 379 | 185 | $226.84 |
| J1953 | Injection, levetiracetam, 10 mg | 75 | 53 | $221.46 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 925 | 550 | $213.54 |
| 82272 | 30 | 24 | $203.75 | |
| 90647 | 18 | 12 | $200.05 | |
| 92650 | 16 | 12 | $197.38 | |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg | 40 | 24 | $197.09 |
| J9370 | Vincristine sulfate, 1 mg | 313 | 149 | $197.04 |
| 80156 | 13 | 12 | $196.83 | |
| J2060 | Injection, lorazepam, 2 mg | 1,708 | 1,201 | $193.55 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 1,738 | 1,286 | $184.24 |
| 99327 | 13 | 13 | $176.98 | |
| 96040 | 13 | 12 | $176.40 | |
| C1726 | Catheter, balloon dilatation, non-vascular | 974 | 779 | $172.78 |
| 93041 | 131 | 54 | $172.58 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 755 | 562 | $171.03 |
| 87899 | 95 | 82 | $170.25 | |
| J3480 | Injection, potassium chloride, per 2 meq | 2,592 | 1,574 | $169.20 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 1,614 | 1,410 | $160.86 |
| 96411 | 1,139 | 648 | $150.08 | |
| 86698 | 18 | 12 | $146.31 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 5,262 | 3,200 | $144.24 |
| J3590 | Unclassified biologics | 15 | 13 | $144.06 |
| 86635 | 17 | 12 | $141.09 | |
| 86612 | 19 | 12 | $134.65 | |
| 86001 | 25 | 16 | $133.67 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 1,254 | 569 | $125.13 |
| 00952 | 138 | 108 | $124.50 | |
| 90672 | 12 | 12 | $123.50 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 3,864 | 3,262 | $122.66 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 651 | 431 | $119.38 |
| C1729 | Catheter, drainage | 409 | 270 | $118.35 |
| 87255 | 12 | 12 | $111.38 | |
| 0121A | 102 | 97 | $101.29 | |
| G0010 | Administration of hepatitis b vaccine | 370 | 281 | $96.65 |
| 98967 | 24 | 24 | $92.12 | |
| 91300 | 6,515 | 5,704 | $91.68 | |
| 96380 | 186 | 185 | $91.01 | |
| 84597 | 13 | 13 | $90.87 | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | 28 | 25 | $90.45 |
| 83529 | 41 | 35 | $87.37 | |
| 84591 | 31 | 26 | $87.13 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,299 | 1,716 | $86.51 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 453 | 361 | $79.40 |
| J3411 | Injection, thiamine hcl, 100 mg | 414 | 213 | $79.18 |
| 0173A | 133 | 128 | $79.08 | |
| 69220 | 13 | 12 | $78.97 | |
| 00918 | 17 | 13 | $77.12 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 188 | 171 | $73.42 |
| J2540 | Injection, penicillin g potassium, up to 600,000 units | 124 | 99 | $71.34 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 178 | 125 | $69.07 |
| 81000 | 131 | 96 | $61.79 | |
| J9267 | Injection, paclitaxel, 1 mg | 1,284 | 542 | $60.64 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 116 | 62 | $55.44 |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 28 | 27 | $55.24 |
| J1171 | Injection, hydromorphone, 0.1 mg | 303 | 224 | $54.65 |
| 88364 | 16 | 13 | $53.01 | |
| J2305 | Injection, nitroglycerin, 5 mg | 114 | 96 | $52.54 |
| 36140 | 17 | 13 | $49.86 | |
| 87071 | 108 | 84 | $49.56 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 925 | 825 | $49.06 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 486 | 421 | $47.24 |
| 72020 | 24 | 24 | $47.03 | |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 689 | 584 | $45.36 |
| 82435 | 94 | 84 | $42.26 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 534 | 454 | $39.84 |
| J1630 | Injection, haloperidol, up to 5 mg | 236 | 184 | $38.08 |
| 83051 | 18 | 12 | $37.31 | |
| 85347 | 39 | 25 | $36.03 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 137 | 124 | $35.44 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 349 | 191 | $34.68 |
| 01402 | 44 | 24 | $33.55 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 16 | 12 | $32.74 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 84 | 65 | $31.36 |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 72 | 12 | $29.01 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 668 | 619 | $26.02 |
| 87430 | 68 | 53 | $25.98 | |
| L8509 | Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type | 14 | 12 | $25.85 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 311 | 145 | $21.40 |
| 96167 | 21 | 20 | $20.13 | |
| 89343 | 70 | 47 | $20.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 6,083 | 4,524 | $18.92 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 222 | 204 | $18.91 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 104 | 91 | $15.70 |
| 91312 | 3,241 | 1,602 | $14.88 | |
| 87185 | 18 | 13 | $14.36 | |
| 90611 | 93 | 35 | $13.89 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 217 | 209 | $11.68 |
| J0737 | Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg | 14 | 13 | $8.46 |
| J0736 | Injection, clindamycin phosphate, 300 mg | 47 | 43 | $7.15 |
| J0456 | Injection, azithromycin, 500 mg | 316 | 222 | $6.26 |
| 91305 | 1,005 | 783 | $5.94 | |
| 91307 | 802 | 558 | $5.44 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 1,734 | 758 | $5.29 |
| 91308 | 750 | 338 | $4.98 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 259 | 238 | $4.74 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 438 | 383 | $3.29 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 147 | 76 | $3.20 |
| Q4049 | Finger splint, static | 79 | 76 | $2.63 |
| J1956 | Injection, levofloxacin, 250 mg | 15 | 12 | $2.30 |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 183 | 169 | $1.58 |
| 91315 | 108 | 65 | $1.06 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 355 | 321 | $0.87 |
| J0290 | Injection, ampicillin sodium, 500 mg | 31 | 27 | $0.82 |
| 91306 | 17 | 17 | $0.14 | |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 14 | 13 | $0.14 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 16 | 15 | $0.13 |
| 91303 | 13 | 12 | $0.11 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 422 | 373 | $0.07 |
| 3078F | 295,319 | 275,834 | $0.02 | |
| 3074F | 326,000 | 304,012 | $0.00 | |
| 3075F | 16,734 | 15,834 | $0.00 | |
| 3079F | 46,930 | 43,743 | $0.00 | |
| 3080F | 2,184 | 2,048 | $0.00 | |
| 3044F | 225 | 223 | $0.00 | |
| 1220F | 105 | 101 | $0.00 | |
| 31629 | 24 | 12 | $0.00 | |
| 1123F | 370 | 320 | $0.00 | |
| 1111F | 91 | 73 | $0.00 | |
| A9561 | Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries | 199 | 185 | $0.00 |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 95 | 77 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 238 | 168 | $0.00 |
| 87808 | 43 | 42 | $0.00 | |
| J2787 | Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml | 16 | 13 | $0.00 |
| J1110 | Injection, dihydroergotamine mesylate, per 1 mg | 47 | 20 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 60 | 40 | $0.00 |
| 91317 | 42 | 42 | $0.00 | |
| C1753 | Catheter, intravascular ultrasound | 18 | 12 | $0.00 |
| C1733 | Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip | 15 | 13 | $0.00 |
| Q9968 | Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg | 12 | 12 | $0.00 |
| 82985 | 15 | 14 | $0.00 | |
| C1759 | Catheter, intracardiac echocardiography | 27 | 13 | $0.00 |
| A9567 | Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries | 18 | 13 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 30 | 27 | $0.00 |
| 3077F | 11,214 | 10,575 | $0.00 | |
| J9190 | Injection, fluorouracil, 500 mg | 2,050 | 746 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 2,229 | 1,909 | $0.00 |
| 3046F | 200 | 173 | $0.00 | |
| C2625 | Stent, non-coronary, temporary, with delivery system | 213 | 179 | $0.00 |
| 00402 | 405 | 290 | $0.00 | |
| 99091 | 15 | 13 | $0.00 | |
| C1758 | Catheter, ureteral | 171 | 128 | $0.00 |
| 1124F | 18 | 15 | $0.00 | |
| 98966 | 16 | 16 | $0.00 | |
| 3051F | 12 | 12 | $0.00 | |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 52 | 43 | $0.00 |
| 43450 | 16 | 13 | $0.00 | |
| J3250 | Injection, trimethobenzamide hcl, up to 200 mg | 38 | 26 | $0.00 |
| 0502F | 16 | 14 | $0.00 | |
| C1762 | Connective tissue, human (includes fascia lata) | 16 | 16 | $0.00 |